Skip to main navigation Skip to search Skip to main content

Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer

G. S. Falchook, S. L. Moulder, J. J. Wheler, Y. Jiang, C. C. Bastida, R. Kurzrock

    Research output: Contribution to journal › Article › peer-review

    33   Link opens in a new tab Scopus citations

    Fingerprint

    Dive into the research topics of 'Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer'. Together they form a unique fingerprint.
    Sort by

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science